Drug Development in China: Opportunities and Challenges

1
Drug Development in China Opportunities and
Challenges Cross Border Bio-partnering and
Investing
The China Life Sciences Partnering Forum -
Shenzhen
By Mark Engel President and CEO Excel
PharmaStudies The Leading CRO in China Beijing
Shanghai Guangzhou Chongqing Chengdu -
Nanjing
2
Where are the Opportunities?

• What is the Product?
• Personal View This means to me a product that is
  less than 5 USD. For services, this means
  services at 30 or less as compared to the West.
• What is the Distribution?
• Who are the People?

3
Chinas Strength

• No Legacy Systems
• Lack of Start Up Capital
• Lower Priced Labor Pool
• An ability to Export
• Government Support
• Educational Emphasis in Sciences
• Example of 100,000 chemists in school today

4
CRA Entry Level Position

• RESUME
• Name Dong Tian Yu
• Sex Female
• Residence location Shanghai
• Birth date Dec. 1976 Education College
• Graduated from Shanghai No.2 Medical University
• Major Clinical Medicine
• 1995.9 ------ 1998.7 Study in Luoyang Medical
  College Clinical Medicine
• 2001.9 ----2004.7 Study in Shanghai No.2
  Medical University Clinical Medicine
• 1998.7 ----- 2000.2 Luoyang CITIC HMC
  Central Hospital Resident
  Physician
• 2001.2-----2002.1 Paul Hartmann (Shanghai)
  Trade Co. Ltd Medical Representative
• 2002.3 ----- 2003.7 Dynamic Medicine Co. Ltd
  Medical
  Representative
• 2004.3------2005.7 Shanghai Careway
  Medi-pharm Technology Co. Ltd CRA
• English Level Have certificate for CET6.
• Computer Level Have certificate for National
  Computer Rank Examination (Grade 2). Familiar
  with MS office software.
• ADD Room 1001, No.4 lane 251 Xie Tu Road , Lu
  Wan District, Shanghai(200023)
• Mobile Telephone xxxxxxxxxxxx

5
Data Management Entry Position

• Curriculum Vitae
• Name Sampson Wang Age27 Gender Male
  Birthplace Shandong, China Marital status
  Single Language Chinese, English
• Educational Background
• 9.2000-7.2003 Medical Master School of Public
  Health, Fudan University, China 9.1994-7.1999
  Medical Bachelor Weifang Medical College,
  Shandong, China
• Professional Background
• 10.2004-Present Data Management Specialist Excel
  PharmaStudies Inc.
• 3.2003-10.2004 Researcher Chinese Center for
  Disease Prevention and Control
• Main Experiences in Clinical Research
• 4.2003-6.2003 Data Management and Statistical
  Analysis (Psychiatric Drug, Import Registration)
  Data Edit Check Statistical Analysis
  Participating
• Training
• 7.2003-10.2004 Base and Statistical Analysis of
  SAS, Chinese Center for Disease Prevention and
  Control, Beijing, China
• 3.2003-6.2003 Procedure, Methods and SAS Programs
  of Data Management, Statistical Analysis Methods,
  SAP and Clinical Research Theories and Methods,
  etc., MOH, Beijing
• 9.2000-7.2001 SAS v6.12, SPSS, EPI DATA, EPI
  INFO, Statistics, Epidemiology, Clinical Trial
  School of Public Health, Fudan University, China,
  Shanghai, China
• 9.1997-7.1998 SAS, Statistics, Epidemiology,
  Weifang Medical College, Shandong, China,
  Shandong, China

6
Where am I partnering/investing (an Angels
view)?

• Technology enhanced providers for local markets
  where the product is low cost and has a large
  market
• Export of supplies, devices, diagnostics, etc.
• Finished generics (I am not in biotech but see
  huge opportunities)
• Clinical Related Opportunities

7
Interesting Partnering Models

• Bringing Sales in Return for Equity
• Co-Invest with Local Expertise

8
Contacts at Excel

• Mark Engel, President
• Office (8621) 5383-4000
• Beijing Office (8610) 8203-1400
• Mobile [phone]
• E-Mail mark.engel_at_excel-china.com
• Xu Ning, COO
• Beijing Office (8610) 8208-1400
• Mobile [phone]
• E-Mail ning.xu_at_excel-china.com